vs

Side-by-side financial comparison of Edwards Lifesciences (EW) and Lineage, Inc. (LINE). Click either name above to swap in a different company.

Edwards Lifesciences is the larger business by last-quarter revenue ($1.6B vs $1.4B, roughly 1.2× Lineage, Inc.). Edwards Lifesciences runs the higher net margin — 23.1% vs -7.3%, a 30.4% gap on every dollar of revenue. On growth, Edwards Lifesciences posted the faster year-over-year revenue change (16.7% vs 3.1%).

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter.

Norwegian Cruise Line Holdings (NCLH) is a holding company that is based in the United States and domiciled in Bermuda. It operates three cruise lines as wholly owned subsidiaries: Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. With its subsidiaries combined, it is the third-largest cruise operator in the world. It is a publicly traded company listed on the New York Stock Exchange.

EW vs LINE — Head-to-Head

Bigger by revenue
EW
EW
1.2× larger
EW
$1.6B
$1.4B
LINE
Growing faster (revenue YoY)
EW
EW
+13.6% gap
EW
16.7%
3.1%
LINE
Higher net margin
EW
EW
30.4% more per $
EW
23.1%
-7.3%
LINE

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
EW
EW
LINE
LINE
Revenue
$1.6B
$1.4B
Net Profit
$380.7M
$-100.0M
Gross Margin
78.0%
32.3%
Operating Margin
1.8%
2.5%
Net Margin
23.1%
-7.3%
Revenue YoY
16.7%
3.1%
Net Profit YoY
6.8%
79.4%
EPS (diluted)
$0.66
$-0.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EW
EW
LINE
LINE
Q1 26
$1.6B
Q4 25
$1.6B
Q3 25
$1.6B
$1.4B
Q2 25
$1.5B
$1.4B
Q1 25
$1.4B
$1.3B
Q4 24
$1.4B
$1.3B
Q3 24
$1.4B
$1.3B
Q2 24
$1.4B
$1.3B
Net Profit
EW
EW
LINE
LINE
Q1 26
$380.7M
Q4 25
$91.2M
Q3 25
$291.1M
$-100.0M
Q2 25
$333.2M
$-6.0M
Q1 25
$358.0M
$0
Q4 24
$385.6M
$-71.0M
Q3 24
$3.1B
$-485.0M
Q2 24
$366.3M
$-68.0M
Gross Margin
EW
EW
LINE
LINE
Q1 26
78.0%
Q4 25
78.1%
Q3 25
77.8%
32.3%
Q2 25
77.5%
31.9%
Q1 25
78.7%
32.2%
Q4 24
78.9%
32.3%
Q3 24
80.6%
32.8%
Q2 24
79.9%
33.4%
Operating Margin
EW
EW
LINE
LINE
Q1 26
1.8%
Q4 25
9.6%
Q3 25
19.8%
2.5%
Q2 25
26.8%
1.7%
Q1 25
27.9%
4.3%
Q4 24
22.6%
-1.6%
Q3 24
25.9%
-38.6%
Q2 24
26.8%
5.5%
Net Margin
EW
EW
LINE
LINE
Q1 26
23.1%
Q4 25
5.8%
Q3 25
18.7%
-7.3%
Q2 25
21.7%
-0.4%
Q1 25
25.3%
Q4 24
27.8%
-5.3%
Q3 24
226.7%
-36.3%
Q2 24
26.7%
-5.1%
EPS (diluted)
EW
EW
LINE
LINE
Q1 26
$0.66
Q4 25
$0.16
Q3 25
$0.50
$-0.44
Q2 25
$0.56
$-0.03
Q1 25
$0.61
$0.01
Q4 24
$0.65
$-0.52
Q3 24
$5.13
$-2.44
Q2 24
$0.61
$-0.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EW
EW
LINE
LINE
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
Stockholders' EquityBook value
$8.4B
Total Assets
$19.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EW
EW
LINE
LINE
Q1 26
Q4 25
$4.2B
Q3 25
$3.8B
Q2 25
$4.1B
Q1 25
$3.9B
Q4 24
$4.0B
$173.0M
Q3 24
$4.4B
$409.0M
Q2 24
$2.0B
$73.0M
Stockholders' Equity
EW
EW
LINE
LINE
Q1 26
Q4 25
$10.3B
Q3 25
$10.2B
$8.4B
Q2 25
$10.5B
$8.6B
Q1 25
$10.1B
$8.6B
Q4 24
$10.0B
$8.6B
Q3 24
$9.5B
$9.0B
Q2 24
$7.4B
$4.9B
Total Assets
EW
EW
LINE
LINE
Q1 26
Q4 25
$13.7B
Q3 25
$13.3B
$19.2B
Q2 25
$13.5B
$19.4B
Q1 25
$13.0B
$18.8B
Q4 24
$13.1B
$18.7B
Q3 24
$13.0B
$19.3B
Q2 24
$10.1B
$18.8B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EW
EW
LINE
LINE
Operating Cash FlowLast quarter
$230.0M
Free Cash FlowOCF − Capex
$35.0M
FCF MarginFCF / Revenue
2.5%
Capex IntensityCapex / Revenue
14.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EW
EW
LINE
LINE
Q1 26
Q4 25
$450.9M
Q3 25
$573.7M
$230.0M
Q2 25
$290.2M
$258.0M
Q1 25
$280.4M
$139.0M
Q4 24
$-127.5M
Q3 24
$351.8M
$186.0M
Q2 24
$371.5M
$155.0M
Free Cash Flow
EW
EW
LINE
LINE
Q1 26
Q4 25
$353.5M
Q3 25
$516.2M
$35.0M
Q2 25
$240.9M
$95.0M
Q1 25
$224.4M
$-12.0M
Q4 24
$-177.3M
Q3 24
$299.9M
$33.0M
Q2 24
$286.1M
$-31.0M
FCF Margin
EW
EW
LINE
LINE
Q1 26
Q4 25
22.5%
Q3 25
33.2%
2.5%
Q2 25
15.7%
7.0%
Q1 25
15.9%
-0.9%
Q4 24
-12.8%
Q3 24
22.1%
2.5%
Q2 24
20.9%
-2.3%
Capex Intensity
EW
EW
LINE
LINE
Q1 26
Q4 25
6.2%
Q3 25
3.7%
14.2%
Q2 25
3.2%
12.1%
Q1 25
4.0%
11.7%
Q4 24
3.6%
Q3 24
3.8%
11.5%
Q2 24
6.2%
13.9%
Cash Conversion
EW
EW
LINE
LINE
Q1 26
Q4 25
4.94×
Q3 25
1.97×
Q2 25
0.87×
Q1 25
0.78×
Q4 24
-0.33×
Q3 24
0.11×
Q2 24
1.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EW
EW

Segment breakdown not available.

LINE
LINE

Warehousing Operations$883.0M64%
Other$308.0M22%
Warehouse Lease$60.0M4%
Food Sales$52.0M4%
E Commerce And Other$46.0M3%
Railcar Lease$23.0M2%
Service Other$5.0M0%

Related Comparisons